StreetInsider.com News Articles

Form 4 Progyny, Inc. For: Jul 14 Filed by: Cummings Melissa B

Thu, 16 Jul 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260716/26779891.html

Form 4 Progyny, Inc. For: Jul 14 Filed by: Cummings Melissa B

Thu, 16 Jul 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260716/26779891.html

Form 144 Progyny, Inc. Filed by: Cummings Melissa B

Tue, 14 Jul 2026 09:46:00 -0400

si-local-file:///var/storage/secattach/20260714/26766210.html

Form 144 Progyny, Inc. Filed by: Cummings Melissa B

Tue, 14 Jul 2026 09:46:00 -0400

si-local-file:///var/storage/secattach/20260714/26766210.html

'Progyny (PGNY) should have a nice beat and raise'; PT Raised to $35 at KeyBanc

Mon, 13 Jul 2026 07:22:57 -0400

(Updated - July 13, 2026 7:22 AM EDT)

KeyBanc analyst Scott Schoenhaus raised the price target on Progyny (NASDAQ: PGNY) to $35.00 (from $30.00) while maintaining an Overweight rating.

The analyst commented: "We believe PGNY should have a nice beat and raise supported by utilization topping consensus (we saw a nice acceleration in June in transactions & spend, see below). That said, we see the focus of the earnings call will be centered around the selling season, which we believe is continuing to see strength (particularly vs. last year). We believe PGNY is still targeting ~1 million added lives for next year

'Progyny (PGNY) should have a nice beat and raise'; PT Raised to $35 at KeyBanc

Mon, 13 Jul 2026 07:22:57 -0400

(Updated - July 13, 2026 7:22 AM EDT)

KeyBanc analyst Scott Schoenhaus raised the price target on Progyny (NASDAQ: PGNY) to $35.00 (from $30.00) while maintaining an Overweight rating.

Form 4 Progyny, Inc. For: Jun 17 Filed by: Clapp Geoffrey

Tue, 23 Jun 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260623/26679521.html

Form 4 Progyny, Inc. For: Jun 17 Filed by: Clapp Geoffrey

Tue, 23 Jun 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260623/26679521.html

Progyny (PGNY) PT Raised to $33 at Truist Securities

Mon, 22 Jun 2026 09:49:57 -0400

(Updated - June 22, 2026 9:49 AM EDT)

Truist Securities analyst Jailendra Singh raised the price target on Progyny (NASDAQ: PGNY) to $33.00 (from $30.00) while maintaining a Buy rating.

The analyst commented: "Fertile Ground for Sustained Growth and Share Gains; Detailed 2-Day NDR Takeaways: We hosted Progyny (PGNY) management - CEO Pete Anevski, CFO Mark Livingston, and VP of IR James Hart - for two days of Midwest investor meetings in Chicago and Minneapolis. The key message from these meetings was that the company remains a highly differentiated fertility benefits platform, built around superior clinical outcomes, comprehensive member support, and deep

Progyny (PGNY) PT Raised to $33 at Truist Securities

Mon, 22 Jun 2026 09:49:57 -0400

(Updated - June 22, 2026 9:49 AM EDT)

Truist Securities analyst Jailendra Singh raised the price target on Progyny (NASDAQ: PGNY) to $33.00 (from $30.00) while maintaining a Buy rating.

Form SCHEDULE 13G/A Progyny, Inc. Filed by: KLEINER PERKINS CAUFIELD & BYERS XIII, LLC

Mon, 08 Jun 2026 12:26:00 -0400

si-local-file:///var/storage/secattach/20260608/26616201.html

Form SCHEDULE 13G/A Progyny, Inc. Filed by: KLEINER PERKINS CAUFIELD & BYERS XIII, LLC

Mon, 08 Jun 2026 12:26:00 -0400

si-local-file:///var/storage/secattach/20260608/26616201.html

Form 4 Progyny, Inc. For: Jun 03 Filed by: Anevski Peter